Avidity Biosciences, Inc.
RNA
Revenue
2.05M
▼-1.50M▼-42.28%
3 Months ChangeAssets
1.35B
▲395.95M▲41.61%
3 Months ChangeLiabilities
126.39M
▲5.81M▲4.82%
3 Months ChangeFree Cash Flow
-71.30M
▼-20.51M▼-40.38%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001599901-24-000176
2024-10-03
Form 8-K
ID: 0001599901-24-000164
2024-08-15
Form 8-K
ID: 0001599901-24-000144
2024-08-09
Form 10-Q
ID: 0001599901-24-000142
2024-08-09
Form 8-K
ID: 0001599901-24-000141
2024-08-09
Form 8-K
ID: 0001599901-24-000135
2024-06-14
Form 8-K
ID: 0001599901-24-000085
2024-06-14
Form 8-K
ID: 0001599901-24-000083
2024-06-12
Form 8-K
ID: 0001599901-24-000080
2024-05-15
Form 8-K
ID: 0001193125-24-138959